EUVIMEDEUVIMED entdecken
Crossref

Intracerebral Delivery of rhFGF20 via Heparin-Poloxamer Hydrogel Promotes Neurological Recovery in Ischemic Stroke

Shasha Ye iD, Yeli Zhao iD, Yuyun Xu, Fei Liang, Rendi Wu iD, Yujie Zhang, Chengkun Cao, Jiana Li, Yichen Wang, Xue Wang, Keyang Chen iD, Li Lin iD

Stroke · 2025

DOI: 10.1161/strokeaha.125.050828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2025. Verfasst von Shasha Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences (S.Y., Y. Zhao, Y.X., F.L., R.W., Y. Zh…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Drug Delivery Systems, Ischemic Stroke, Infarction, Middle Cerebral Artery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ischemic stroke poses a significant threat to human health. FGF (fibroblast growth factor) 20 is involved in the repair of central nervous system diseases, but it has the shortcomings of short half-life and inability to penetrate the blood-brain barrier. Therefore, to overcome the drawbacks of rhFGF20 (recombinant human FGF20) and explore its role in ischemic stroke, the effects of intracerebral administration of rhFGF20 by heparin-poloxamer hydrogel (HP-rhFGF20 [heparin-poloxamer hydrogel-encapsulated rhFGF20]) in a rat stroke model were the focus of this study. METHODS: A rat model of middle cerebral artery occlusion/reperfusion and oxygen-glucose deprivation-reoxygenation models were established to mimic ischemic stroke in vivo and in vitro, respectively. Endogenous FGF20 levels were measured in patients, ischemic rats, and oxygen-glucose deprivation-reoxygenation–injured neurons. To assess the therapeutic potential, rhFGF20 was administered intracerebrally via heparin-poloxamer hydrogel implants (1 mg/mL, 20 μL) on day 5 poststroke. 2,3,5-Triphenyltetrazolium chloride staining, neurobehavioral tests (including the mNSS test [modified Neuro-Severity Score], the corner test, the rotarod test, the cylinder test, and the Morris water maze test), and Nissl staining were performed to evaluate neurological recovery. Immunofluorescence and Western blotting were conducted to assess the brain repair processes (neurogenesis, neuronal remodeling, and angiogenesis). RESULTS: High expression of FGF20 was detected in the serum of patients with ischemic stroke, the cortex of ischemic rats, and oxygen-glucose deprivation-reoxygenation–injured neurons. Heparin-poloxamer increased the stability and bioavailability of rhFGF20. HP-rhFGF20 attenuated neurobehavioral deficits and infarct volume in ischemic stroke rats. HP-rhFGF20 inhibited neuronal cell death, microglial activation, and glial scar formation on day 7 post-implantation. Moreover, HP-rhFGF20 promoted the proliferation, migration, and differentiation of neural stem cells and improved neuronal plasticity and angiogenesis in ischemic stroke rats. CONCLUSIONS: HP-rhFGF20 promoted functional recovery in ischemic stroke rats by enhancing neurogenesis and angiogenesis. The combination of growth factors and biomaterials provides a promising therapeutic strategy for central nervous system diseases. REGISTRATION: URL: http://www.chictr.org.cn ; Unique identifier: ChiCTR2100051104.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsDrug Delivery SystemsIschemic StrokeInfarction, Middle Cerebral ArteryMaleAnimalsRatsRats, Sprague-DawleyRecombinant ProteinsHydrogelsHeparinPoloxamerInjections, IntralesionalTreatment OutcomeDrug Evaluation, PreclinicalDrug LiberationBrainNeurogenesisNeural Stem CellsNeovascularization, PhysiologicDisease Models, AnimalHumansCase-Control Studies

Stichwörter der Autor:innen

blood-brain barrierfibroblast growth factorhydrogelsischemic strokestem cells

Substanzen

FGF20 protein, humanFibroblast Growth FactorsRecombinant ProteinsHydrogelsHeparinPoloxamer

Autor:innen und Institutionen

  • State Key Laboratory of Macromolecular Drugs and Large-Scale Manufacturing, School of Pharmaceutical Sciences (S.Y., Y. Zhao, Y.X., F.L., R.W., Y. Zhang, C.C., J.L., Y.W., X.W., L.L.), Wenzhou Medical University, China.
  • Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital (K.C.), Wenzhou Medical University, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Science (L.L.), Wenzhou Medical University, China.

ORCID-Profile: Shasha Ye, Yeli Zhao, Rendi Wu, Keyang Chen, Li Lin

Zitieren

APA

Ye, S., Zhao, Y., Xu, Y., Liang, F., Wu, R., Zhang, Y., Cao, C., Li, J., Wang, Y., Wang, X., Chen, K., & Lin, L. (2025). Intracerebral Delivery of rhFGF20 via Heparin-Poloxamer Hydrogel Promotes Neurological Recovery in Ischemic Stroke. Stroke. https://doi.org/10.1161/strokeaha.125.050828

Vancouver

Ye S, Zhao Y, Xu Y, Liang F, Wu R, Zhang Y, et al. Intracerebral Delivery of rhFGF20 via Heparin-Poloxamer Hydrogel Promotes Neurological Recovery in Ischemic Stroke. Stroke. 2025. doi:10.1161/strokeaha.125.050828

BibTeX
@article{Ye2025,
  author = {Ye, Shasha and Zhao, Yeli and Xu, Yuyun and Liang, Fei and Wu, Rendi and Zhang, Yujie and Cao, Chengkun and Li, Jiana and Wang, Yichen and Wang, Xue and Chen, Keyang and Lin, Li},
  title = {Intracerebral Delivery of rhFGF20 via Heparin-Poloxamer Hydrogel Promotes Neurological Recovery in Ischemic Stroke},
  journal = {Stroke},
  year = {2025},
  doi = {10.1161/strokeaha.125.050828}
}
Kostenlos starten →